ID

14287

Description

Viapaed Study In Children And Adolescents With Asthma; ODM derived from: https://clinicaltrials.gov/show/NCT00315744

Lien

https://clinicaltrials.gov/show/NCT00315744

Mots-clés

  1. 07/04/2016 07/04/2016 -
Détendeur de droits

CC BY-NC 3.0

Téléchargé le

7 avril 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Asthma NCT00315744

Eligibility Asthma NCT00315744

  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00315744
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
children aged 4 to 16 years with an established history of perennial asthma.
Description

age, perennial asthma

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C0004096
subjects who are treated with an inhaled corticosteroid according to bdp (budesonide) 200-400 µg/day or equivalent during the last 4 weeks before run-in.
Description

inhaled corticosteroid

Type de données

boolean

Alias
UMLS CUI [1]
C0586793
15 minutes after inhaling 200µg of salbutamol, reversible increase in fev1 of at least 12% of the pre-dose value.
Description

fev1 salbutamol

Type de données

boolean

Alias
UMLS CUI [1,1]
C0748133
UMLS CUI [1,2]
C0001927
willingness to substitute previous controller medication on the twice daily inhalation of fluticasone 100µg bid via diskus®.
Description

willingness to substitute previous controller medication on the twice daily inhalation of fluticasone 100µg bid via diskus®.

Type de données

boolean

Alias
UMLS CUI [1]
C1321605
UMLS CUI [2]
C0082607
subjects/guardians who have given written informed consent to participate in the study.
Description

written informed consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
subjects /guardians who are able to understand and complete a diary record card (drc).
Description

ability to understand and complete a diary record card

Type de données

boolean

Alias
UMLS CUI [1]
C1321605
subjects who are able to use a mini-wright peak flow meter.
Description

mini-wright peak flow meter

Type de données

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C0180915
sexually active female adolescents must use adequate contraception.
Description

contraception

Type de données

boolean

Alias
UMLS CUI [1]
C0700589
willingness to refrain from any other controller medication (including anti-leukotrienes) or from regular use of short-acting beta agonists or anticholinergics during the treatment period.
Description

willingness to refrain from any other controller medication (including anti-leukotrienes) or from regular use of short-acting beta agonists or anticholinergics during the treatment period

Type de données

boolean

Alias
UMLS CUI [1]
C1321605

Similar models

Eligibility Asthma NCT00315744

  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00315744
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
age, perennial asthma
Item
children aged 4 to 16 years with an established history of perennial asthma.
boolean
C0001779 (UMLS CUI [1])
C0004096 (UMLS CUI [2])
inhaled corticosteroid
Item
subjects who are treated with an inhaled corticosteroid according to bdp (budesonide) 200-400 µg/day or equivalent during the last 4 weeks before run-in.
boolean
C0586793 (UMLS CUI [1])
fev1 salbutamol
Item
15 minutes after inhaling 200µg of salbutamol, reversible increase in fev1 of at least 12% of the pre-dose value.
boolean
C0748133 (UMLS CUI [1,1])
C0001927 (UMLS CUI [1,2])
willingness to substitute previous controller medication on the twice daily inhalation of fluticasone 100µg bid via diskus®.
Item
willingness to substitute previous controller medication on the twice daily inhalation of fluticasone 100µg bid via diskus®.
boolean
C1321605 (UMLS CUI [1])
C0082607 (UMLS CUI [2])
written informed consent
Item
subjects/guardians who have given written informed consent to participate in the study.
boolean
C0021430 (UMLS CUI [1])
ability to understand and complete a diary record card
Item
subjects /guardians who are able to understand and complete a diary record card (drc).
boolean
C1321605 (UMLS CUI [1])
mini-wright peak flow meter
Item
subjects who are able to use a mini-wright peak flow meter.
boolean
C1321605 (UMLS CUI [1,1])
C0180915 (UMLS CUI [1,2])
contraception
Item
sexually active female adolescents must use adequate contraception.
boolean
C0700589 (UMLS CUI [1])
willingness to refrain from any other controller medication (including anti-leukotrienes) or from regular use of short-acting beta agonists or anticholinergics during the treatment period
Item
willingness to refrain from any other controller medication (including anti-leukotrienes) or from regular use of short-acting beta agonists or anticholinergics during the treatment period.
boolean
C1321605 (UMLS CUI [1])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial